Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ILMN · against 1,336 other Healthcare companies
Ranked #663 of 1,337 · scores higher than 50% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 50–59, including ILMN · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | ILMN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 2.3% | 1.5% | 55% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 3.1% | 4.2% | 44% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 2.7% | -1.0% | 65% | 20% | |
| Book yieldHigher is better · 1,306 reported | 7.9% | 37.9% | 13% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 663 | 558.5B INR (≈$6.7B) | 50 | 47 | |
| 663 | 2.5B USD | 50 | 32 | |
| 663 | 521.3B INR (≈$6.3B) | 50 | 69 | |
| 663 | 15.6B DKK (≈$2.3B) | 50 | 33 | |
| 663 | 36.0B USD | 50 | 46 | |
| 663 | 9.0B USD | 50 | 78 | |
| 663 | 6.3B USD | 50 | 78 | |
| 663 | 126.5B USD | 50 | 56 | |
| 663 | 38.4B USD | 50 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score